We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
The specific formulation for the aesthetic medicine indication of Dysport is under European Union regulatory approval.
2
Botulinum toxins (Botox, Dysport etc) still rank as the number one non-surgical procedure followed by hyaluronic acid filler treatments.
3
Early in the treatment programme, three patients who received a dose of 1000 units Dysport showed systemic side-effects and generalized muscle weakness.
4
Dysport was initially developed as a treatment of movement disorders or muscle spasticity, and has now been approved for aesthetic indications in 20 countries.
5
A unit at the world's biggest food group that makes Botox rival Dysport may fetch at least 6 billion Swiss francs ($6 billion).